Mackenzie L. Hawes

Mackenzie L. Hawes

Auto-generated profile, based on publicly available information

Mackenzie L. Hawes

Department of Medicine, Section of Hematology and Oncology, Tulane University School of Medicine, New Orleans, USA

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 August 2025 in Oncogene
Verified
Journal Article
Open access
PDF file
MHMackenzie L. Hawes
Mackenzie L. Hawes
MMMarcus A. Moody
Marcus A. Moody
CMCaroline R. McCauley
Caroline R. McCauley
AHAbigail G. Huddleston
Abigail G. Huddleston
MSMaansi Solanky
Maansi Solanky
EMElizabeth Martin
Elizabeth Martin
Extracellular matrix (ECM) components are key regulators in breast cancer progression, as ECM remodeling is essential for breast cancer cells to invade into surrounding tissue. This process is characterized by the alignment of fibrillar collagens, breakdown of basement membrane components, and increased interstitial collagen stiffness. In patients with obesity, pre-existing ECM changes, including excessive collagen deposition and heightened matrix stiffness, mimic alterations detected in breast cancer. Given that obesity is a predictor of poor prognosis and resistance to treatment in breast cancer, it is crucial to understand how ECM conditioned by obesity affects disease outcomes. In this review, we highlight known ECM changes that occur with breast cancer and obesity and describe how these changes impact cancer cell metastasis, disease progression, and the breast cancer tumor microenvironment. We examine how obesity driven ECM remodeling affects treatment response and resistance. Further, we discuss how the compounding factor of age contributes to remodeling and current preclinical models of ECM in breast cancer.

24 July 2025 in Frontiers in Bioscience-Landmark
Verified
Journal Article
Open access
CMCaroline R. McCauley
Caroline R. McCauley
TFTamara R. Fischer
Tamara R. Fischer
NCNicole M. Cullen
Nicole M. Cullen
MHMackenzie L. Hawes
Mackenzie L. Hawes
KSKhudeja Salim
Khudeja Salim
Bruce BunnellBruce Bunnell
Bruce Bunnell
Adipose-derived stem cells (ASCs) have been extensively investigated for regeneration and tissue engineering applications owing to their inherent regenerative ability. However, the effects of various species and depot-specific extraction sites on ASC differentiation and renewal capacity have yet to be explored thoroughly, limiting the clinical use of ASCs. Despite promising clinical results, ASCs are also associated with poor disease outcomes, specifically in the context of breast cancer and obesity. Only when ASC-driven obesity and breast cancer are understood separately will the connection between the two diseases and the ASC-associated effects therein be fully established. Therefore, this review aimed to assess the behavioral differences of ASCs from various large mammalian species and human-derived anatomical niches. This review analyzes ASC migration, the role of ASCs in breast cancer progression and immune modulation, and breast cancer-driven ASC dysfunction to further the understanding of ASCs for future clinical applications.